Resumo

LOPEZ VALERO, Raquel; LOPEZ VALERO, Manuel  e  PULIDO SANCHEZ, María Dolores. Patient Safety E.I.M.I treated in a UCCyU: implementation of NANDA-NOC-NIC. Ene. [online]. 2016, vol.10, n.1. ISSN 1988-348X.

Or REMICADE^® infliximab is a chimeric monoclonal antibody, used to reduce the inflammatory cascade in inflammatory diseases. The objectives of this research is to standardize clinical practice in patients treated with infliximab, decrease variability of care and improve the safety of these patients. It made a record of nursing diagnoses, NOC and NIC with the highest incidence seen in patients treated with E.I.M.I Inflixibab, with which you can perform nursing care quality, achieving the record and ensure proper transmission of information on care.

Palavras-chave : Inflammation; Diagnosis; Equipment Safety; Quality of Health Care.